Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 272 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Zarogoulidis, Paul [Clear All Filters]
Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours..
J Cancer. 5(8), 646-54.
(2014). A gene therapy induced emphysema model and the protective role of stem cells..
Diagn Pathol. 9, 195.
(2014). Genes' Interactions: A Major Contributor to the Malignant Transformation of Endometriosis..
Int J Mol Sci. 20(8),
(2019). Hamman's syndrome (spontaneous pneumomediastinum presenting as subcutaneous emphysema): A rare case of the emergency department and review of the literature..
Respir Med Case Rep. 23, 63-65.
(2018). Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections..
Int J Gen Med. 5, 175-82.
(2012). Heimlich valve and pneumothorax..
Ann Transl Med. 3(4), 54.
(2015). Human immunodeficiency virus infection and pneumothorax..
J Thorac Dis. 6(Suppl 4), S377-82.
(2014). Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy..
Pharmaceutics. 16(4),
(2024). Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery..
Pharmaceutics. 15(10),
(2023). Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study..
Drug Des Devel Ther. 7, 611-7.
(2013). Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment..
Respir Med Case Rep. 22, 197-202.
(2017). Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma..
Respir Med Case Rep. 22, 283-286.
(2017). In vivo synergistic cytogenetic effects of aminophylline on lymphocyte cultures from patients with lung cancer undergoing chemotherapy..
Mutat Res. 740(1-2), 1-5.
(2012). Influence of apnoeic oxygenation in respiratory and circulatory system under general anaesthesia..
J Thorac Dis. 6 Suppl 1, S116-45.
(2014). Inhaled chemotherapy adverse effects: mechanisms and protection methods..
Lung Cancer Manag. 8(4), LMT19.
(2020). Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients..
Future Oncol. 9(9), 1307-13.
(2013). Inhaled Cisplatin for NSCLC: Facts and Results..
Int J Mol Sci. 20(8),
(2019). Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it"..
Ther Deliv. 3(8), 919-21.
(2012). Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer..
Future Oncol. 9(8), 1171-94.
(2013). Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible..
J Cancer. 9(6), 1121-1126.
(2018). Inhaled insulin: too soon to be forgotten?.
J Aerosol Med Pulm Drug Deliv. 24(5), 213-23.
(2011). Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment..
Drug Des Devel Ther. 8, 1753-63.
(2014). Intensive care unit and lung cancer: when should we intubate?.
J Thorac Dis. 5 Suppl 4, S407-12.
(2013). Interferon-γ and Colorectal Cancer: an up-to date..
J Cancer. 9(2), 232-238.
(2018). Interleukin-6 cytokine: a multifunctional glycoprotein for cancer..
Immunome Res. 9(62), 16535.
(2013).